C07C 307/04
Diamides of sulfuric acids
C07C307/04 (Diamides of sulfuric acids) appears on 250 US grants and 258 published applications in this corpus.
Search patents in C07C- Granted patents
- 250
- Published applications
- 258
- Assignees
- 163
- Inventors
- 872
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 6 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 7 | 0 |
| 1995 | 1 | 0 |
| 1996 | 8 | 0 |
| 1997 | 5 | 0 |
| 1998 | 6 | 0 |
| 1999 | 5 | 0 |
| 2000 | 8 | 0 |
| 2001 | 13 | 0 |
| 2002 | 14 | 14 |
| 2003 | 13 | 12 |
| 2004 | 2 | 19 |
| 2005 | 9 | 7 |
| 2006 | 10 | 9 |
| 2007 | 14 | 13 |
| 2008 | 4 | 11 |
| 2009 | 6 | 11 |
| 2010 | 4 | 19 |
| 2011 | 4 | 7 |
| 2012 | 7 | 14 |
| 2013 | 14 | 13 |
| 2014 | 9 | 13 |
| 2015 | 15 | 8 |
| 2016 | 6 | 9 |
| 2017 | 6 | 10 |
| 2018 | 8 | 9 |
| 2019 | 6 | 6 |
| 2020 | 7 | 7 |
| 2021 | 5 | 7 |
| 2022 | 3 | 2 |
| 2023 | 3 | 13 |
| 2024 | 7 | 10 |
| 2025 | 7 | 10 |
| 2026 | 2 | 5 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Calpain-2 inhibitor compounds and methods of treatment21 Apr 2026US 12,606,520 B2Western University of Health Sciences
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives21 Apr 2026US 12,606,522 B2OrsoBio, Inc.
- Phenylalanine-based LAT1 inhibitors and uses thereof30 Sep 2025US 12,427,124 B1Maxymune Therapeutics, Inc.
- Modulators of liver receptor homologue 1 (LRH-1) and uses16 Sep 2025US 12,415,770 B2Emory University Office of Technology Transfer
- 17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof12 Aug 2025US 12,384,753 B2Enanta Pharmaceuticals, Inc.
- Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives16 Jul 2026US 2026/0200844 A1OrsoBio, Inc.
- Compounds and compositions for treating conditions associated with nlrp activity16 Jul 2026US 2026/0200880 A1Novartis AG
- Modulators of liver receptor homologue 1 (lrh-1) and uses25 Jun 2026US 2026/0176228 A1Emory University
- Compounds and compositions for intracellular delivery of therapeutic agents12 Mar 2026US 2026/0069549 A1ModernaTX, Inc.
- Modulators of liver receptor homologue 1 (lrh-1) and uses26 Feb 2026US 2026/0055046 A1Emory University
Most cited
By later US patents
- Sulfonamide inhibitors of aspartyl protease147US 5,585,397 AVertex Pharmaceuticals Incorporated · 1996
- Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method125US 5,760,246 A1998
- IL-8 receptor antagonists92US 5,886,044 ASmithKline Beecham Corporation · 1999
- Compounds and compositions for intracellular delivery of therapeutic agents88US 10,857,105 B2MordernaTX, Inc. · 2020
- IL-8 receptor antagonists88US 5,780,483 ASmithKline Beecham Corporation · 1998